246 related articles for article (PubMed ID: 26306030)
21. Recent progress on inhibitors of the type II transmembrane serine proteases, hepsin, matriptase and matriptase-2.
Damalanka VC; Janetka JW
Future Med Chem; 2019 Apr; 11(7):743-769. PubMed ID: 30945556
[TBL] [Abstract][Full Text] [Related]
22. Utilization of biotinylated diphenyl phosphonates for disclosure of serine proteases.
Hawthorne S; Hamilton R; Walker BJ; Walker B
Anal Biochem; 2004 Mar; 326(2):273-5. PubMed ID: 15003568
[No Abstract] [Full Text] [Related]
23. Synthesis and SAR of benzamidine factor Xa inhibitors containing a vicinally-substituted heterocyclic core.
Fevig JM; Pinto DJ; Han Q; Quan ML; Pruitt JR; Jacobson IC; Galemmo RA; Wang S; Orwat MJ; Bostrom LL; Knabb RM; Wong PC; Lam PYS ; Wexler RR
Bioorg Med Chem Lett; 2001 Mar; 11(5):641-5. PubMed ID: 11266160
[TBL] [Abstract][Full Text] [Related]
24. Potent inhibitors of human matriptase-1 based on the scaffold of sunflower trypsin inhibitor.
Fittler H; Avrutina O; Empting M; Kolmar H
J Pept Sci; 2014 Jun; 20(6):415-20. PubMed ID: 24723440
[TBL] [Abstract][Full Text] [Related]
25. Screening of benzamidine-based thrombin inhibitors via a linear interaction energy in continuum electrostatics model.
Nicolotti O; Giangreco I; Miscioscia TF; Convertino M; Leonetti F; Pisani L; Carotti A
J Comput Aided Mol Des; 2010 Feb; 24(2):117-29. PubMed ID: 20148287
[TBL] [Abstract][Full Text] [Related]
26. Discovery of nonbenzamidine factor VIIa inhibitors using a biaryl acid scaffold.
Bolton SA; Sutton JC; Anumula R; Bisacchi GS; Jacobson B; Slusarchyk WA; Treuner UD; Wu SC; Zhao G; Pi Z; Sheriff S; Smirk RA; Bisaha S; Cheney DL; Wei A; Schumacher WA; Hartl KS; Liu E; Zahler R; Seiler SM
Bioorg Med Chem Lett; 2013 Sep; 23(18):5239-43. PubMed ID: 23927973
[TBL] [Abstract][Full Text] [Related]
27. Design and synthesis of redox stable analogues of sunflower trypsin inhibitors (SFTI-1) on solid support, potent inhibitors of matriptase.
Jiang S; Li P; Lee SL; Lin CY; Long YQ; Johnson MD; Dickson RB; Roller PP
Org Lett; 2007 Jan; 9(1):9-12. PubMed ID: 17192072
[TBL] [Abstract][Full Text] [Related]
28. Tuning activity-based probe selectivity for serine proteases by on-resin 'click' construction of peptide diphenyl phosphonates.
Serim S; Mayer SV; Verhelst SH
Org Biomol Chem; 2013 Sep; 11(34):5714-21. PubMed ID: 23884325
[TBL] [Abstract][Full Text] [Related]
29. Structure/function aspects of neutral P1 residue peptide inhibitors of thrombin.
Deadman J; Claeson G; Scully MF
J Enzyme Inhib; 1995; 9(1):29-41. PubMed ID: 8568564
[TBL] [Abstract][Full Text] [Related]
30. Inhibition of batroxobin, a serine proteinase from Bothrops snake venom, by derivatives of benzamidine.
Stürzebecher J; Stürzebecher U; Markwardt F
Toxicon; 1986; 24(6):585-95. PubMed ID: 3529503
[TBL] [Abstract][Full Text] [Related]
31. Development of Trypsin-Like Serine Protease Inhibitors as Therapeutic Agents: Opportunities, Challenges, and their Unique Structure-Based Rationales.
Liang G; Bowen JP
Curr Top Med Chem; 2016; 16(13):1506-29. PubMed ID: 26369819
[TBL] [Abstract][Full Text] [Related]
32. Design and chemical syntheses of potent matriptase-2 inhibitors based on trypsin inhibitor SFTI-1 isolated from sunflower seeds.
Gitlin-Domagalska A; Dębowski D; Łęgowska A; Stirnberg M; Okońska J; Gütschow M; Rolka K
Biopolymers; 2017 Nov; 108(6):. PubMed ID: 28555756
[TBL] [Abstract][Full Text] [Related]
33. 1,2-Benzisothiazol-3-one 1,1-dioxide inhibitors of human mast cell tryptase.
Combrink KD; Gülgeze HB; Meanwell NA; Pearce BC; Zulan P; Bisacchi GS; Roberts DG; Stanley P; Seiler SM
J Med Chem; 1998 Nov; 41(24):4854-60. PubMed ID: 9822554
[TBL] [Abstract][Full Text] [Related]
34. Design of benzamidine-type inhibitors of factor Xa.
Gabriel B; Stubbs MT; Bergner A; Hauptmann J; Bode W; Stürzebecher J; Moroder L
J Med Chem; 1998 Oct; 41(22):4240-50. PubMed ID: 9784099
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of human alpha-, beta- and gamma-thrombin by mono-, bis-, tris- and tetra-benzamidine structures: thermodynamic study.
Ascenzi P; Fruttero R; Amiconi G; Pugliese L; Bolognesi M; Coletta M; Onesti S; Guarneri M; Menegatti E
J Enzyme Inhib; 1992; 6(2):131-9. PubMed ID: 1284429
[TBL] [Abstract][Full Text] [Related]
36. Modification of the N-terminal sulfonyl residue in 3-amidinophenylalanine-based matriptase inhibitors.
Steinmetzer T; Dönnecke D; Korsonewski M; Neuwirth C; Steinmetzer P; Schulze A; Saupe SM; Schweinitz A
Bioorg Med Chem Lett; 2009 Jan; 19(1):67-73. PubMed ID: 19036586
[TBL] [Abstract][Full Text] [Related]
37. Inhibition activities of natural products on serine proteases.
Jedinák A; Maliar T; Grancai D; Nagy M
Phytother Res; 2006 Mar; 20(3):214-7. PubMed ID: 16521112
[TBL] [Abstract][Full Text] [Related]
38. Design, synthesis, and biological activity of potent and selective inhibitors of blood coagulation factor Xa.
Willardsen JA; Dudley DA; Cody WL; Chi L; McClanahan TB; Mertz TE; Potoczak RE; Narasimhan LS; Holland DR; Rapundalo ST; Edmunds JJ
J Med Chem; 2004 Jul; 47(16):4089-99. PubMed ID: 15267248
[TBL] [Abstract][Full Text] [Related]
39. Amido-(propyl and allyl)-hydroxybenzamidines: development of achiral inhibitors of factor Xa.
Gong Y; Pauls HW; Spada AP; Czekaj M; Liang G; Chu V; Colussi DJ; Brown KD; Gao J
Bioorg Med Chem Lett; 2000 Feb; 10(3):217-21. PubMed ID: 10698439
[TBL] [Abstract][Full Text] [Related]
40. Development of substrate analogue inhibitors for the human airway trypsin-like protease HAT.
Sielaff F; Böttcher-Friebertshäuser E; Meyer D; Saupe SM; Volk IM; Garten W; Steinmetzer T
Bioorg Med Chem Lett; 2011 Aug; 21(16):4860-4. PubMed ID: 21741839
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
